Fiji vs Myanmar: Share of pregnant women with HIV that receive antiretroviral therapy
Fiji
57.0%
in 2024
Myanmar
54.0%
in 2024
Fiji rank
63rd
Myanmar rank
65th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Fiji
- Myanmar
How they compare
Fiji currently reports 57.0% against 54.0% in Myanmar, a difference of 3.0%.
That makes Fiji's figure about 1.1 times Myanmar's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Fiji ranks 63rd and Myanmar ranks 65th of 84 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Fiji | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.4% | 13.8% | 12.6% | Fiji |
| 2010s | 71.6% | 69.7% | 1.9% | Fiji |
| 2020s | 31.0% | 51.8% | 20.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Fiji or Myanmar?
- Fiji, at 57.0% against 54.0% in Myanmar as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Fiji and Myanmar?
- 3.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Myanmar rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Fiji ranks 63rd and Myanmar ranks 65th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.